Moderna Entangles Pfizer/BioNTech In COVID-19 Vaccine Patent Lawsuits: All You Need To Know
Moderna Inc (NASDAQ: MRNA) has
AstraZeneca’s CEO Says There Are No COVID Regrets, Looks For Oncology Acquisitions
In a Reuters report, AstraZeneca Plc's (NASDAQ:
Looking Into Moderna’s Recent Short Interest
Moderna's (NASDAQ:MRNA) short percent of float has fallen 9.47% since its last report. The company recently reported that it has 14.73 million shares sold short, which is 4.3% of all regular shares that are available for trading.
Moderna Plans US Application Submission For COVID-19 Omicron Adapted Booster ‘Very Soon’
Moderna Inc (NASDAQ:MRNA) plans to file data with the FDA very soon, seeking approval for a booster shot targeting…
‘Moderna Set to Seek FDA Approval of Booster Against Omicron Variants’ -Bloomberg
https://www.bloomberg.com/news/articles/2022-08-23/moderna-says-us-filing-imminent-for-booster-against-new-variants?sref=y3YMCJ4e#xj4y7vzkg
Moderna Whale Trades For August 23
A whale with a lot of money to spend has taken a noticeably bearish stance on Moderna.
Looking at options history for Moderna (NASDAQ:MRNA) we detected 53 strange trades.
Jim Cramer Is Staying Away From This Stock, Says It’s The ‘Best One Of A Bad Neighborhood’
On CNBC’s "Mad Money Lightning Round," Jim Cramer said ChargePoint Holdings, Inc.
Moderna to Supply 12M Doses of Omicron-Adapted COVID-19 Booster To Canada
Moderna Inc (NASDAQ:MRNA) will supply 12 million doses of its COVID-19 shot adapted to target the Omicron variant of the coronavirus…